AI Verdict
KALV has stronger fundamentals based on our AI analysis.
KANP vs KALV Fundamental Comparison
| Metric | KANP | KALV |
|---|---|---|
| Revenue | $1.6M | $13.7M |
| Net Income | $-3.7M | $-158.9M |
| Net Margin | -226.5% | -1,160.0% |
| ROE | -4.8% | -934.8% |
| ROA | -4.3% | -46.7% |
| Current Ratio | N/A | 7.22x |
| Debt/Equity | 0.00x | 0.31x |
| EPS | $-2.02 | $-2.97 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KANP vs KALV: Frequently Asked Questions
Is KANP or KALV a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KALV has stronger fundamentals. KANP is rated SELL (78% confidence) while KALV is rated HOLD (45% confidence). This is not investment advice.
How does KANP compare to KALV fundamentally?
KAANAPALI LAND LLC has ROE of -4.8% vs KalVista Pharmaceuticals, Inc.'s -934.8%. Net margins are -226.5% vs -1,160.0% respectively.
Which stock pays higher dividends, KANP or KALV?
KANP has a dividend yield of N/A or no dividend while KALV has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KANP or KALV for long term?
For long-term investing, consider that KANP has SELL rating with 78% confidence, while KALV has HOLD rating with 45% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KANP vs KALV?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KANP vs KALV, the AI consensus favors KALV based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.